What other newspapers are saying: FDA’s recent performance embarrassing
The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the wrong reasons, and the dysfunction could have life and death consequences for patients. The biotech firm UniQure on Monday reported that the FDA had moved the goalposts for approving its Huntington’s disease gene therapy. There are currently no approved drugs that can slow progression of the brutal neuro-degenerative disease, which afflicts about 40,000 Americans. The FDA in April ...